公开(公告)号：US20220151984A1

公开(公告)日：2022-05-19

申请号：US17588033

申请日：2022-01-28

Applicant: TASLY PHARMACEUTICAL GROUP CO., LTD.

Inventor： He SUN ,  Xijun YAN ,  Naifeng WU ,  Kaijing YAN ,  Yonghong ZHU ,  Shunnan ZHANG ,  Xiaolin BAI ,  Xiaohui MA ,  Yi HE ,  Ting LI ,  Lei LI

IPC: A61K31/357 ,  A61K36/82 ,  A61K47/24 ,  A61K9/48 ,  A61K31/205 ,  A61P1/16 ,  A61K9/16 ,  A61K31/355 ,  A61K31/683 ,  A61K9/08 ,  A61K36/488

Abstract: A pharmaceutical composition is prepared from the following raw materials (in parts by weight): silybin (8.75-60), phospholipid (15-65), a Pu'er tea extract (25-200), and vitamin E (6.25-40). The composition has the effect of treating non-alcoholic fatty liver diseases.

公开(公告)号：US20150352168A1

公开(公告)日：2015-12-10

申请号：US14654151

申请日：2013-12-19

Applicant: TASLY PHARMACEUTICAL GROUP CO., LTD.

Inventor： Xijun YAN ,  Naifeng WU ,  Shunnan ZHANG ,  Jianhui YANG ,  Yan LIU ,  Xingyun SHAO ,  Song GAO ,  Lina DONG ,  Xiaolin BAI ,  Yan SUN ,  Bo XU ,  Yongfeng ZHENG ,  Lijun FAN

IPC: A61K36/804 ,  A61K36/236 ,  A61K36/65 ,  A61K36/74 ,  A61K36/268 ,  A61K36/536 ,  A61K36/482 ,  A61K35/618 ,  A61K36/66 ,  A61K36/232 ,  A61K36/48

CPC classification number: A61K36/74 ,  A61K9/1623 ,  A61K9/1652 ,  A61K35/618 ,  A61K36/232 ,  A61K36/236 ,  A61K36/268 ,  A61K36/48 ,  A61K36/482 ,  A61K36/486 ,  A61K36/505 ,  A61K36/536 ,  A61K36/65 ,  A61K36/66 ,  A61K36/71 ,  A61K36/804 ,  A61K36/9068 ,  A61K2236/00 ,  A61K2300/00

Abstract: A pharmaceutical composition for treating headache, prepared from eleven Chinese herbal medicines: Chinese angelica root, ligusticum chuanxiong, radix paeoniae lactiflorae, prepared rhizome of rehmannia, uncaria tomentosa, leatherleaf milletia, prunella vulgaris, sicklesenna seed, pearl shell, corydalis tuber, and asarum, and a proper amount of adjuvant materials. A preparation method of the pharmaceutical composition, and uses thereof in the preparation of drugs for treating various headaches, traumatic cranial nerve syndrome, dizziness and vertigo, vexation and irritability, insomnia and dreaminess.

Abstract translation: 一种用于治疗头痛的药物组合物，由十一种中草药制成：当归，川e，芍药，制备的地黄，un草，皮革小米，普通pr子，sick藜籽，珍珠贝，延胡索块茎， ，以及适量的辅料。 药物组合物的制备方法及其在制备用于治疗各种头痛，创伤性颅神经综合征，头晕和眩晕，烦躁和烦躁，失眠和梦幻的药物中的用途。

公开(公告)号：US20230201293A1

公开(公告)日：2023-06-29

申请号：US17920888

申请日：2021-04-28

Applicant: TASLY PHARMACEUTICAL GROUP CO., LTD.

Inventor： He SUN ,  Xuefeng SU ,  Zhiyong ZHONG ,  Anni LI ,  Xijun YAN ,  Naifeng WU ,  Kaijing YAN

IPC: A61K36/537 ,  A61K36/258 ,  A61K31/05 ,  A61K9/51 ,  A61P11/00

CPC classification number: A61K36/537 ,  A61K36/258 ,  A61K31/05 ,  A61K9/5123 ,  A61K9/5161 ,  A61K9/5146 ,  A61P11/00

Abstract: The present invention relates to an application of a traditional Chinese medicine composition and formulation thereof in the preparation of medicaments for preventing and/or treating novel coronavirus pneumonia.

公开(公告)号：US20180104215A1

公开(公告)日：2018-04-19

申请号：US15560560

申请日：2016-03-22

Applicant: TASLY PHARMACEUTICAL GROUP CO., LTD.

Inventor： He SUN ,  Xijun YAN ,  Naifeng WU ,  Kaijing YAN ,  Yonghong ZHU ,  Shunnan ZHANG ,  Xiaolin BAI ,  Xiaohui MA ,  Yi HE ,  Ting LI ,  Lei LI

IPC: A61K31/357 ,  A61K31/205 ,  A61K36/82 ,  A61K47/24 ,  A61P1/16

CPC classification number: A61K31/357 ,  A61K9/08 ,  A61K9/1617 ,  A61K9/1682 ,  A61K9/48 ,  A61K31/205 ,  A61K31/355 ,  A61K31/683 ,  A61K36/488 ,  A61K36/82 ,  A61K47/24 ,  A61K2236/19 ,  A61P1/16

Abstract: A pharmaceutical composition for treating non-alcoholic fatty liver diseases. The pharmaceutical composition is prepared from 8.75-60 parts by weight of silybin, 15-65 parts by weight of phospholipid, 25-150 parts by weight of a Pu'er tea extract, and 10.425-60 parts by weight of L-carnitine.

公开(公告)号：US20180104216A1

公开(公告)日：2018-04-19

申请号：US15560583

申请日：2016-03-22

Applicant: TASLY PHARMACEUTICAL GROUP CO., LTD.

Inventor： Xijun YAN ,  Naifeng WU ,  He SUN ,  Kaijing YAN ,  Yonghong ZHU ,  Xiaohui MA ,  Shunnan ZHANG ,  Changwen LI ,  Xiaolin BAI ,  Ting LI ,  Lei LI ,  Yi HE

IPC: A61K31/357 ,  A61K36/82 ,  A61K36/488 ,  A61K47/24 ,  A61P1/16

CPC classification number: A61K31/357 ,  A61K9/08 ,  A61K9/1617 ,  A61K9/1682 ,  A61K9/48 ,  A61K31/205 ,  A61K31/355 ,  A61K31/683 ,  A61K36/488 ,  A61K36/82 ,  A61K47/24 ,  A61K2236/19 ,  A61P1/16

Abstract: Disclosed are a pharmaceutical composition for treating non-alcoholic fatty liver and a method for preparing same. The composition is prepared from the following hulk drugs by weight ratio: 8.75-60 parts of silibinin, 15-65 parts of phospholipid, 25-200 parts of Pu'er tea extract, and 5-50 parts of radix puerariae extract.

公开(公告)号：US20180055817A1

公开(公告)日：2018-03-01

申请号：US15560568

申请日：2016-03-22

Applicant: TASLY PHARMACEUTICAL GROUP CO., LTD.

Inventor： He SUN ,  Xijun YAN ,  Naifeng WU ,  Kaijing YAN ,  Yonghong ZHU ,  Shunnan ZHANG ,  Xiaolin BAI ,  Xiaohui MA ,  Yi HE ,  Ting LI ,  Lei LI

IPC: A61K31/357 ,  A61K31/683 ,  A61K36/82 ,  A61K31/355 ,  A61K31/205 ,  A61K9/16

CPC classification number: A61K31/357 ,  A61K9/08 ,  A61K9/1617 ,  A61K9/1682 ,  A61K9/48 ,  A61K31/205 ,  A61K31/355 ,  A61K31/683 ,  A61K36/488 ,  A61K36/82 ,  A61K47/24 ,  A61K2236/19 ,  A61P1/16

Abstract: A pharmaceutical composition. The pharmaceutical composition is prepared from the following raw materials in parts by weight: 8.75-60 parts of silybin, 15-65 parts of phospholipid, 25-200 parts of a Pu'er tea extract, 6.25-40 parts of vitamin E, and 8.3-60 parts of L-carnitine. The composition can be used for treating non-alcoholic fatty liver diseases.

公开(公告)号：US20180042893A1

公开(公告)日：2018-02-15

申请号：US15560578

申请日：2016-03-22

Applicant: TASLY PHARMACEUTICAL GROUP CO., LTD.

Inventor： Naifeng WU ,  Xijun YAN ,  He SUN ,  Kaijirig YAN ,  Yonghong ZHU ,  Shunnan ZHANG ,  Xiaolin BAI ,  Yi HE ,  Xiaohni MA ,  Ting LI

IPC: A61K31/357 ,  A61K47/24 ,  B65D81/32 ,  A61K36/82

CPC classification number: A61K31/357 ,  A61K9/0095 ,  A61K9/145 ,  A61K9/1617 ,  A61K9/2013 ,  A61K9/4858 ,  A61K36/82 ,  A61K47/24 ,  A61K2236/19 ,  B65D81/32 ,  A61K2300/00

Abstract: A pharmaceutical composition for treating non-alcoholic fatty liver diseases consists of a silybin-phospholipid complex preparation and Pu'er tea/tea product according to a weight ratio of 0.5-2.5:0.3-10, wherein the silybin-phospholipid complex capsule preparation and the Pu'er teat/tea product are separately packaged.

公开(公告)号：US20180042892A1

公开(公告)日：2018-02-15

申请号：US15560576

申请日：2016-03-22

Applicant: TASLY PHARMACEUTICAL GROUP CO., LTD.

Inventor： Naifeng WU ,  Xijun YAN ,  He SUN ,  Kaijing YAN ,  Yonghong ZHU ,  Shunnan ZHANG ,  Xiaolin BAI ,  Yi HE ,  Xiaohui MA ,  Ting LI ,  Lei LI

IPC: A61K31/357 ,  A61K36/82 ,  A61K47/24 ,  A61K9/08 ,  A61K9/16

Abstract: Disclosed is a pharmaceutical composition containing silibinin, which is prepared from the following bulk drugs by weight ratio: 8.75-60 parts of silibinin, 15-65 parts of phospholipid, and 25-200 parts of Pu'er tea extract. The drug has the function of treating non-alcoholic fatty liver.